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Objectives To assess feasibility of a future randomised controlled
trial (RCT) of clinical and cost-effectiveness of lifestyle
information and commercial weight management groups to
support postnatal weight management to 12 months post-birth.
Design Two-arm feasibility trial, with nested mixed-methods
process evaluation.
Setting Inner-city unit, south England.
Population Women with body mass indices (BMIs) ≥25 kg/m2 at
pregnancy booking or normal BMIs (18.5–24.9 kg/m2) identified
with excessive gestational weight gain at 36 weeks of gestation.
Methods Randomised to standard care plus commercial weight
management sessions commencing 8–16 weeks postnatally or
standard care only.
Main outcomes Feasibility outcomes included assessment of
recruitment, retention, acceptability and economic data collation.
Primary and secondary end points included difference between
groups in weight 12 months postnatally compared with booking
(proposed primary outcome for a future trial), diet, physical
activity, smoking, alcohol, mental health, infant feeding, NHS
resource use.
Results In all, 193 women were randomised: 98 intervention and
95 control; only four women had excessive gestational weight
gain. A slightly greater weight change was found among
intervention women at 12 months, with greatest benefit. Among
women attending ten or more weight management sessions. There
was >80% follow up to 12 months, low risk of contamination and
no group differences in trial completion.
Conclusion It was feasible to recruit and retain women with BMIs
≥25 kg/m2 to an intervention to support postnatal weight
management; identification of excessive gestational weight gain requires
consideration. Economic modelling could inform out-of-trial costs and
benefits in a future trial. A definitive trial is an important next step.
Keywords Feasibility, postnatal, randomised controlled trial,
weight management.
Tweetable abstract A feasibility RCT of postnatal weight support
showed women with BMIs ≥25 kg/m2 can be recruited and
followed to 12 months postnatally.
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Maternal medicine
Introduction
At 6–8 weeks postnatally, two-thirds of women have a
higher weight than before pregnancy,1 with postpartum
weight retention contributing to poorer long-term health2,3
and failure to breastfeed.4,5 There is limited evidence for
pregnancy-specific weight management interventions.6–8 A
meta-analysis of individual participant data of diet and
physical activity interventions9 reported less gestational
weight gain in intervention than control groups, but no
significant reductions in other outcomes of interest.
The USA Institute of Medicine defines clinically significant
weight loss in the general population as ≥5% of initial weight
within 6 months of the intervention, a reduction associated
with fewer weight morbidities,10 although smaller weight loss
may result in health gains.11 A Cochrane review of diet and/
or exercise for postnatal weight reduction12 found that exer-
cise alone was not effective (two trials, n = 53, mean differ-
ence 0.10 kg, 95% CI 1.90 to 1.71), but diet (one trial,
n = 45, mean difference 1.70 kg, 95% CI 2.08 to 0.132)
or diet plus exercise (seven trials, n = 573, mean difference
1.93 kg, 95% CI 2.96 to 0.89) was effective. Data were
insufficient to infer other potential risks or benefits for
women or infants.12
Interventions to reduce postpartum weight retention
across all body mass index (BMI) categories have included
counselling, individualised physical activity plans, healthy
eating groups and clinic visits. In one systematic review,
seven of eleven trials found a decrease in weight retention,
six including diet and physical activity interventions.2 No
study considered cost-effectiveness, with wide heterogeneity
in approaches to intervention implementation. Dalrymple
et al.13 reviewed lifestyle interventions in overweight and
obese women for postpartum weight management. Seven
postpartum-only interventions showed significant improve-
ments in weight compared with controls, suggesting poten-
tial for weight management.
A general population study of individuals with obese or
overweight BMIs (n = 740) indicated that commercial
weight loss programmes (where an individual can choose
from a range of options and providers to suit their lifestyle
and budget, including group or online interventions) may be
more beneficial than healthcare-based programmes (which
may include a prescribed programme of contacts with a clin-
ician in a healthcare setting).14 Commercial weight pro-
grammes achieved better weight loss at programme end
(mean difference 2.3 kg; 1.3–3.4 kg) and were approximately
£40 cheaper per person than primary-care services.
This single centre, two-arm individually randomised fea-
sibility trial with a nested mixed-methods process evalua-
tion assessed the feasibility of conducting a future
definitive randomised controlled trial (RCT) to determine
effectiveness and cost-effectiveness of lifestyle information
and access to a commercial weight management group
(Slimming World) to support longer-term postnatal
weight management and positive lifestyle behaviour in
women at risk of poor weight management.
Methods
Participant eligibility
Women 18 years and over, speaking and reading English,
with a singleton pregnancy who had not accessed weight
management groups during this pregnancy.
Recruitment
Recruitment, from one inner-city maternity unit, reflected
two approaches. In the first, women with BMIs ≥25 kg/m2
identified from antenatal booking information; at 26 weeks
of gestation, women were sent a letter advising a Research
Midwife (RM) would contact them, which also explained
how the woman could contact the RM if she did not want
to receive further information. Two weeks later, the RM
contacted women who had not asked to be removed from
the contact list, to explain the study. In the second
approach, women with healthy BMIs at antenatal booking
who gained more weight than recommended by US Insti-
tute of Medicine guidelines10 could self-refer, or be referred
by clinicians, to RMs to be weighed at 36 weeks of gesta-
tion (routine weighing is not recommended in NHS ante-
natal care15). As this approach did not succeed, the
protocol was revised to send letters to all women with nor-
mal booking BMIs who were 32–34 weeks of gestation,
inviting them to be weighed for excessive gestational weight
gain at 36 weeks of gestation.
All women received a Patient Information Sheet before
seeking written informed consent from those who agreed
to participate at 36 weeks of gestation.
Intervention
Women received standard care (see below), plus a lifestyle
information leaflet with evidence-informed guidance on
breastfeeding, diet, smoking cessation, reducing alcohol and
managing sleep16,17 and access to a commercial weight
management programme (Slimming World) for 12 weekly
sessions, commencing anytime from 8 to 16 weeks postna-
tally. Women could choose which group they attended and
when they started, to accommodate birth recovery, lifestyle
and family demands. They could take their infants with
them.
Slimming World groups are homogeneous in content
and delivery,18 promoting key behaviour change techniques
including goal setting, social support and positive rein-
forcement, underpinned by social cognitive theory relevant
to motivation and self-efficacy for weight management.19,20
A food optimising system encourages healthy eating,
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recommending that 80% of foods are fruit, vegetables and
satiating foods (carbohydrates and protein); alongside mea-
sured portions of fibre and calcium-rich foods; and an
allowance for foods high in fat or sugar. The plan is
designed to be unrestrictive and adaptable to cultural and
dietary preferences, and includes guidance for breastfeeding
women to ensure key nutritional requirements are met. A
‘Body Magic’ programme promotes the importance of
physical activity.
Women were offered (fees waived) attendance for 12 ses-
sions over 14 consecutive weeks, allowing two ‘holiday’
weeks. To achieve 5% weight loss from baseline, a differ-
ence considered to improve health outcomes (Donnelly
et al.21), attending at least ten sessions is recommended.19
Control group
Standard NHS maternity care to 6–8 weeks postpartum,
including routine midwife, health visitor and general prac-
titioner contacts.
Randomisation
Individual participants were randomly allocated in ratio of
1:1 to intervention or control using a web-based system
developed by King’s Clinical Trials Unit, with relevant data
entered by the RM. Intention-to-treat analysis limited attri-
tion and analytical bias. It was not possible to ‘blind’ RMs
or women to allocation, but those responsible for analyses
were blinded to allocation.
Progression criteria
Progression criteria included recruitment uptake, time to
complete recruitment; retention of women to 12 months
postnatally, acceptability of study procedures and interven-
tion, contamination between study groups, and if relevant
data could be collated to inform an economic evaluation.
Primary and secondary feasibility outcomes
The primary feasibility outcome, to inform the effect size
for a definitive trial, was difference between study groups
in weight 12 months postnatally, expressed as % weight
change and weight loss from documented antenatal book-
ing weight. A core outcome set was not used.
Secondary outcomes were selected as appropriate to
inform progress to a definitive RCT. These included rates
of 5% and 10% weight reduction and changes in relation
to healthy lifestyle and health behaviours. The following
were used (asterisks indicate that they were included at 6
and 12 months):
 Dietary Instrument for Nutritional Education (DINE©,
University of Oxford)22
 International Physical Activity Short-Form23
 Edinburgh Postnatal Depression Scale*24
 Smoking status/cigarette dependence25
 Alcohol Use Disorders Identification Test26
 Rosenberg Self-Esteem Scale27
 Impact on body image*28
 EQ-5D-5L29
 Soft drink intake; breastfeeding intent, uptake and dura-
tion; sleep patterns*; infant health*: questions developed
for the feasibility study
 Adult Service Receipt Schedule (AD-SUS)30
At 6 and 12 months, all women were asked about the
timing and type of postnatal weight support they had
accessed to assess potential contamination and inform
future decisions about timing of commencement of the
intervention offer. An integral mixed-methods process eval-
uation examined the acceptability of the intervention and
study procedures. These findings are reported separately.
Patient and public involvement
A group of four local women who had experienced previ-
ous pregnancies with BMIs of ≥25 kg/m2 were convened at
study development to advise the team on approaches to
recruitment, intervention and outcomes most likely to be
of importance to postnatal women. This group met regu-
larly throughout the study period. VB co-ordinated the
patient and public involvement (PPI) group on behalf of
the SWAN trial team.
Data collection
Information at trial entry, including eligibility, booking
BMI, parity, age, ethnicity, deprivation score, total house-
hold income, birth mode, gestation and birthweight were
obtained from maternity records. The baseline question-
naire was completed at recruitment (36 weeks of gestation).
At 6 and 12 months women met with RMs to be weighed
and complete questionnaires. If women could not meet the
RM, they could return questionnaires by post, recording
their current weight.
Sample size
The proposed sample size was 190, allowing 30% loss to
follow up to achieve data from 130 women at 12 months
post-birth and inform estimates of required sample size for
any clinically important differences to within 30% of true
value. The mean (SD) percentage weight change following
Slimming World’s programme of 12 weekly groups is
5.5% (SD 3.3%).18 Assuming numbers were typical, 65
women in each group were required to detect a difference
of 2% between intervention and control arms with 90%
power at the 5% significance level (two-tailed).
Analysis
Recruitment was assessed as number of women randomised
per month, with 95% CIs derived from the Poisson distri-
bution, and retention as proportion of women randomised
638 ª 2019 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists
Bick et al.
providing analysable data for primary assessment at
12 months. Linear regression was used for the primary end
point and other continuous measures. Adjustment was
made for corresponding measurements made pre-randomi-
sation.31 Binary regression with a log-link was used to
assess risk ratios for all binary outcomes, adjusting for
maternal age, BMI, ethnicity and parity. Following CON-
SORT and other recommendations,32 risk differences were
also estimated. Significance tests were only conducted to
test for differences in dropout rates between groups, and
estimates of treatment effects.
For primary analysis, participants were analysed in the
groups into which they were randomly allocated. Estimated
differences and 95% CIs were calculated for specified pri-
mary and secondary analyses (significance at 5%). Sensitiv-
ity analyses were used to assess robustness of conclusions
to missing outcome data and departures from randomised
treatment
Reduction of weight by more than 5 and 10% at 6 and
12 months were analysed as binary variables, with health
ratios and risk differences presented. Subgroup analysis of
the primary end point among overweight (BMI 25–
29.9 kg/m2) and obese (BMI ≥30 kg/m2) women was pre-
planned, with interaction tests to determine if treatment
effect varied by subgroup.
To explore if women who attended ten or more sessions
had greater 12-month weight loss than women attending nine
or fewer, or control women, or if women who documented
their own weight in questionnaires had different weight
change than women who attended appointments, subgroup
analysis using the per-protocol subgroup was conducted.
Ethical approval
Approval was granted by Health Research Authority Lon-
don – Camberwell St Giles REC on 2 September 2016 (ref-
erence:16/LO/1422) and HRA approval was granted on 11
October 2016.
Funding
This study was funded by the NIHR Public Health
Research Programme; reference no: 14/67/14.
Results
Recruitment and retention
Between November 2016 and July 2017, of 1132 potentially
eligible women, 835 (73.5%) were not recruited, 59 (5.2%)
were later ineligible (e.g. had a premature birth) and contact
data on 43 (3.8%) women were missing from their records.
In most cases, study letters were returned unopened or
phone calls not returned. Women who were contacted and
asked why they would not consider recruitment reported
practical barriers, such as moving house, or not having any
concerns about their weight. Of 195 (17.2%) women who
agreed to attend the recruitment appointment, two changed
their minds; 193 were recruited and randomised, 97% of
whom had BMIs >25 kg/m2 Only four of nine women with a
healthy BMI at booking who responded to a study letter and
met the RMs at 36 weeks of gestation had excessive gesta-
tional weight gain and were eligible to participate.
The CONSORT diagram (Figure 1) shows trial partici-
pant flow. Two women withdrew, one from the control at
6-month follow up, and one from the intervention at
12 months. Neither asked for data to be withdrawn. Only
women who returned a 6-month questionnaire were sent a
12-month questionnaire, 20 women returning a copy by
post; at 12 months, 69/83 (83.1%) intervention group
women and 71/75 (94.6%) control women completed ques-
tionnaires; 32 returned by post.
Baseline characteristics
Antenatal booking BMI data informed study outcome com-
parisons. Customised birthweight centiles33 included cor-
rection for expected birthweight for maternal height,
weight, ethnicity, parity and gestation at delivery (Table 1).
Mean maternal age was 32 years (SD 5.2), and mean
maternal booking BMI was 30.51 kg/m2 (SD 5.4) (Table 1).
More intervention women had a mean BMI ≥30 kg/m2 at
booking and twice as many had planned caesarean section
compared with controls. Mean gestational birth age was
39.4 weeks (SD 2.5), and mean infant birthweight of
3.43 kg (SD 503). Most women lived in areas of highest
social deprivation,34 although a third of women had total
household incomes of ≥£ 61,000. A slightly lower propor-
tion of white women were recruited compared with the
local maternity population, with a slightly higher propor-
tion of Black women.35 Differences between groups at base-
line were not assessed statistically.36
Proposed primary and secondary outcomes
After adjusting the most powerful predictors measured pre-
randomisation, using linear regression and removing any
biases due to chance imbalance at baseline, weight loss at
12 months postnatally was greater than at 6 months (Table 2),
supporting 12 months as a future primary end point.
Pre-planned subgroup analysis of various secondary end
points showed no significant differences between the inter-
vention and control groups (Table 3). There was no evidence
of differences in weight outcomes among women with higher
BMIs who self-reported or were weighed by RMs.
Of the 98 intervention women, 46 (47%) attended one
or more weight management sessions. Based on per-proto-
col analysis, women who attended ten or more sessions
(19/46, 41%) had greater weight loss at 12 months than
women who attended nine or fewer sessions or none at all,
or were control group (95% CI 1.05–8.93, P = 0.013).
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Randomised = 193
Allocated to intervenon 
n = 98
Allocated to control 
n = 95
Lost to follow up n = 13
Could not be contacted
Lost to follow up n = 22; 20 
could not be contacted, 1 
withdrew, 1 requested postal 
Q but no reply 
Analysed for 6-month 
follow up n = 83
Analysed for 6-month 
follow up n = 75
Lost to follow up n = 14. 11 
could not be contacted, 1 
withdrew, 2 requested postal 
Q but no reply
Analysed for 12-month
follow up
n = 69
Analysed for 12-month 
follow up 
n = 71
Lost to follow up n = 4
3 could not be contacted; 1 
woman out of country
Enrolment Assessed for eligibility 
n = 1132
Not recruited (n = 835); moving away; 
not at contact address; could not be 
contacted by telephone
Not meeng inclusion criteria (n = 59)
Contact data missing (n = 43)
Other: 2 women who inially agreed 
declined to be randomised
Figure 1. Participant flow diagram.
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There was no evidence of differences between groups
and dietary intake, physical activity, body image, sleep pat-
terns, tobacco smoking, self-esteem or EQ-5D scores (see
Supplementary material, Tables S1–S7).
With respect to other secondary outcomes, differences
if present were only detected at 6 months. Intervention
women were more likely to be drinking diet or sugar-free
squash than control women (OR 2.84, 95% CI 1.11–7.29,
P = 0.029), with no differences at baseline or 12 months
(see Supplementary material, Table S8). They were also
more likely to have Edinburgh Postnatal Depression Scale
scores ≥12 at 6 months, indicating possible depression
(intervention, 9/83 [10.8%], control 1/75 [1.3%], relative
risk = 8.13 [1.06–62.69], P = 0.01; see Supplementary
material, Table S9) and less likely to drink any alcohol
than control women at 6 months (44/53.0% versus 33/
44.6; P = 0.038, 95% CI 2.719 to 0.083), but not at
baseline or 12 months (see Supplementary material,
Table S10).
At 6 months, most women (95%) reported that they had
breastfed (see Supplementary material, Table S11), although
more control women exclusively breastfed. At 12 months,
over a third continued to breastfeed. Women introduced
their infants to solid foods at a mean age of 22.2 weeks
(SD 3.72) in the intervention and 23.4 weeks (SD 4.78) in
the control. Intervention women stopped breastfeeding ear-
lier than control women (20.0 weeks [SD 14.4] compared
with 24.2 [SD 15.9] weeks).
Acceptability of trial processes and intervention
There was low risk of contamination; only five control
women joined Slimming World and a further four joined a
similar commercial programme. In total, 25/83 (30%)
intervention and 28/75 (37%) control women accessed
additional weight management support at 6 months, with
similar rates at 12 months. Most control women accessed
support 5–6 months postnatally. Joining a gym was most
popular in both groups (30 and 50%, respectively).
There was little or no difference in trial completion
between groups (difference 2.2%, 95% CI 15.2 to 10.8),
and responses to measures showed high overall completion
(>80%, see Supplementary material, Table S12).
Of 46/98 (47%) intervention women who attended at
least one Slimming World session, most accessed the sup-
port 10 weeks postnatally and the mean number of sessions
attended was 6.74 (SD 3.94). Most women continued with
the same group that they started with. Of the 52 women
who did not attend, of 39 (75%) providing reasons, most
described ‘opportunity’ or ‘motivation’ issues, including
that it was too soon after birth, or they did not recognise
they had a weight problem.
Health economics
Selected economic data collection tools to collate informa-
tion from women’s questionnaires and maternity records,
were suitable as a basis for an evaluation of cost-effective-
ness in a definitive trial.
Table 1. Baseline characteristics on all women randomised
Women’s characteristics Intervention Control
Intervention
(n = 98)
Control
(n = 95)
Age (years) 32.44 (5.10) 33.06 (5.37)
Height (m) 1.64 (0.07) 1.64 (0.06)
Maternal weight
Weight (kg) 83.77 (18.77) 80.53 (13.17)
Mean booking BMI (kg/m2) 31.18 (6.47) 29.83 (4.11)
<25, no EGWGa 0 (0.0%) 1 (1.1%)
25–29.9, no EGWG 2 (2.0%) 1 (1.1%)
25–29.9, EGWG 20 (20.4%) 31 (32.6%)
30–34.9, no EGWG 37 (37.8%) 26 (27.4%)
30–34.9, EGWG 9 (9.2%) 18 (18.9%)
35+, no EGWG 14 (14.3%) 11 (11.6%)
35+, EGWG 11 (11.2%) 6 (6.3%)
Ethnicityb
White 38 (38.8%) 40 (42.1%)
Black 40 (40.8%) 36 (37.9%)
Asian 6 (6.1%) 2 (2.1%)
Other 14 (14.3%) 17 (17.9%)
Total household income
£0–£5,475 7 (7.1) 5 (5.2)
£5,476–£15,000 11 (11.2) 9 (9.4)
£16,000–£30,000 14 (14.2) 11 (11.5)
£31,000–£45,000 8 (8.1) 10 (10.5)
£46,000–£60,000 7 (7.1) 11 (11.5)
£61,000+ 32 (32.2) 31 (32.6)
Would not say 19 (19.3) 18 (19.1)
IMD (centile scale)c, d 0.27 (0.15) 0.28 (0.17)
IMD quintiles
1 (least deprived) 2 (2.0%) 2 (2.2%)
2 2 (2.0%) 3 (3.2%)
3 11 (11.2%) 15 (16.1%)
4 49 (50.0%) 41 (44.1%)
5 (most deprived) 34 (34.7%) 32 (34.4%)
Gestation at birth (weeks) 39.38 (1.54) 39.49 (3.36)
Mode of birthd
Vaginal (normal) 45 (46.4%) 53 (56.4%)
Vaginal (assisted) 10 (10.3%) 12 (12.8%)
Planned caesarean section 30 (30.9%) 14 (14.9%)
Emergency caesarean section 10 (10.3%) 14 (14.9%)
Birthweighte 3378.14 (497.51) 3500.00 (505.90)
<10th centile 14/90 (15.6%) 7/89 (7.9%)
<3rd centile 5/90 (5.6%) 2/89 (2.2%)
aEGWG = Excessive gestational weight gain, IoM criteria.
bEthnicity based on UK census categories.
cIMD = Index of Multiple Deprivation [48].
dNumbers are slightly reduced because of some missing values.
eCustomised birthweight centiles [46].
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Discussion
Main findings
It was possible to recruit and retain women with BMIs
≥25 kg/m2 to this feasibility RCT, although approaches to
recruit women with excessive gestational weight gain were
not successful. Intervention women had greater weight loss
at 12 months, with evidence of a ‘dose effect’ in terms of
number of sessions attended, with minimal impacts on
other lifestyle behaviours. It was feasible to combine
women’s self-report and maternity record data to evaluate
within-trial economic impacts.
We aimed to recruit 190 women over 6 months, and
recruited 193 women over 8 months, the additional time
reflecting protocol revisions to identify and recruit women
with excessive gestational weight gain. A high number of
potentially eligible women did not respond to contacts,
which could reflect a number of issues, including that
women had too many other commitments during preg-
nancy, or did not want to consider postnatal weight
management support, but high follow-up rates of women
who were recruited were reassuring.
Our findings provide some support for using measure-
ments at 12 months, rather than 6 months, which our PPI
group agreed with. The difference in weight was slightly
greater at 12 months than at 6 months among intervention
women. If real, this may be because some women had not
yet received the full intervention at 6 months, but could
reflect the need for women to have longer access to fully
adapt to the weight management programme. This would
support findings of a general population trial where indi-
viduals allocated to a 52-week open group weight manage-
ment programme had greater weight loss over a 2-year
period than those randomised to a 12-week programme or
to receive brief advice and self-help materials.37
Secondary outcomes showed minimal differences. Those
which were found (e.g. higher Edinburgh Postnatal Depres-
sion Scale scores at 6 months among intervention women)
are important to consider further in future research given
evidence of physical and psychological co-morbidity in this
Table 2. Average weights and weight changes at antenatal booking, trial entry, 6 and 12 months postnatally adjusted for baseline
Intervention Mean (SD) Control mean (SD) Difference* (95% CI)
Baseline (n) 98 95
Estimated antenatal weight 82.52 (18.77) 79.28 (13.17)
Weight at start of pregnancy (kg) 83.77 (18.77) 80.53 (13.17)
Weight at end of pregnancy (kg) 94.04 (16.93) 89.31 (11.97)
Six months postnatal (n) 82 72
Weight (kg) 83.24 (17.68) 81.88 (12.60)
Adjusted treatment effects
6 months postnatal (n)** 80 71
Weight change (kg) 8.74 (9.73) 6.57 (6.43) 1.66 (4.49 to 1.16)
Weight change (%) 9.56 (11.01) 7.52 (7.24) 1.83 (5.06 to 1.41)
12 months postnatal (n) 69 71
Weight (kg) 82.35 (18.41) 81.89 (14.60)
12 months postnatal (n)** 68 70
Weight change (kg) 10.26 (8.24) 7.50 (7.12) 3.63 (6.45 to  0.81)
Weight change (%) 11.48 (8.96) 8.65 (7.72) 4.02 (6.98 to  1.07)
*Differences in weight change are adjusted for weight at end of pregnancy, maternal age, parity, ethnicity and BMI.
**Numbers are reduced slightly because of missing values for age and parity.
Table 3. Weight reduction by more than 5 and 10% at 6 and 12 months postnatally
Intervention Usual care Health ratio (95% CI) Risk difference (95% CI)
6 months
>5% weight reduction 20/82 (24.4%) 10/72 (13.9%) 1.76 (0.88 to 3.50) 10.5% (1.8 to 22.8)
>10% weight reduction 6/82 (7.3%) 2/72 (2.8%) 2.63 (0.55 to 12.64) 4.5% (2.3 to 11.3)
12 months
>5% weight reduction 16/69 (23.2%) 18/71 (25.4%) 0.91 (0.51 to 1.64) 2.2% (16.4 to 12.0)
>10% weight reduction 9/69 (13.0%) 3/71 (4.2%) 3.09 (0.87 to 10.93) 8.8% (0.4 to 18.0)
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population.38 Few intervention women recalled the lifestyle
information leaflet offered at recruitment, but for women
in late pregnancy/early postnatal period it was unlikely that
healthy lifestyle advice was an immediate priority. For a
definitive trial, providing additional information alongside
weight management support would have to be considered,
including optimal format of dissemination.
There was an apparent dose–response effect on weight
outcomes, with greatest benefit found among women who
attended ten or more Slimming World sessions. A higher
uptake would have been encouraging, however, as the sam-
ple included women from an inner-city area with childcare
and other responsibilities, who may not have encountered
a similar weight management intervention before, that just
under half attended at least one session could be viewed
positively. Previous trials have reported similar uptake of
weight management interventions among those in high-in-
come and low-income areas,39 with potential for targeted
schemes to support weight management among adults liv-
ing in areas of higher social deprivation. Process evaluation
findings will inform uptake and retention strategies for a
future trial.
It was feasible to generate economic data using partici-
pant self-report information and maternity records.
Strengths and limitations
We could recruit pregnant women with high BMIs from
diverse ethnic backgrounds living in an inner-city area, and
follow to 12 months postnatally. Women completed a
broad range of health outcome measures, with no apparent
problems with data completion. The intervention group
women could access sessions at a venue, day and time to
suit their needs and lifestyles, an issue that our PPI group
considered of high importance to support women who had
recently given birth. The programme is standardised and
evidence-based18 and suitable for new mothers, including
those who are breastfeeding.
For a future trial, we have evidence of how to potentially
increase uptake of the intervention, including extending the
duration of ‘offer’ and providing more information about
the programme following group allocation. Women were
willing to meet the RMs at the two scheduled follow-up
contact points, indicating that this approach will support
high data completion in a future trial. PPI support and
advice as the trial progressed enabled any ongoing issues to
be quickly addressed and resolved.
Economic modelling to inform longer-term impacts on
outcomes of importance may be warranted in a future
trial.
Limitations included being unable to identify and recruit
women with excessive gestational weight gain, meaning that
findings are only relevant to women with BMIs >25 kg/m2.
That some measures had not been validated in a postnatal
population meant that validity and interpretation cannot
be confirmed. As a single-centre feasibility study, findings
may not be generalised.
Interpretation in light of other evidence
This is one of the first UK studies to consider a specific
postnatal weight management intervention. The importance
of postnatal intervention is becoming clearer, given con-
cerns about longer-term impacts of maternal obesity, and
lack of evidence of effectiveness of pregnancy-only inter-
ventions.7,8 A recent review of reviews again showed inter-
ventions involving physical activity and/or dietary changes
could be effective in managing postnatal weight, although
findings should be interpreted with caution because of sta-
tistical heterogeneity.39
As women with higher BMIs experience a range of per-
sistent co-morbidities, such as diabetes and hypertensive
disorders,40,41 the timing and content of a postnatal weight
management intervention has to reflect birth recovery,
demands of parenthood, potential return to employment,
social circumstances and mobility of the population. This
study shows that women who were interested in weight
management support were willing to participate and com-
plete the study, but approaches have to be flexible and
reflect each woman’s decision about when she feels timing
of an intervention is appropriate.
Failure to recruit women with excessive gestational
weight gain suggests that these women will remain ‘under
the radar’, with implications for life-course health. UK
guidance15 is that women should not be weighed routinely.
Even contacting women directly did not identify a large
number who met Institute of Medicine criteria for excessive
gestational weight gain at 36 weeks. The potential to
inform lifestyle behaviours was less clear, but could reflect
positive lifestyle behaviours, such as high breastfeeding
uptake, in our local population35 (no data on longer-term
rates were available locally). Integration of evidence, and
discussion of findings with our PPI group, highlighted sev-
eral key findings to optimise intervention uptake in a
definitive study, including offering more information about
the intervention in pregnancy, a longer commencement
period and alternative approaches to presenting informa-
tion on positive health behaviours.
Inclusion of economic modelling of longer-term impacts
could prove an essential vehicle for a more complete and
robust examination of programme cost-effectiveness
Conclusion
Most feasibility objectives were achieved. Process evaluation
findings indicate that if commercial weight management
sessions are to support women with higher BMIs to achieve
and sustain postnatal weight loss and adapt positive
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lifestyle change, a wider window of commencement should
be offered and the duration of the intervention should be
extended. An online intervention arm could counteract
some ‘opportunity’ issues identified by women for not
attending sessions, but evidence of effectiveness of such for-
mats is needed. As economic impacts over the course of a
short-term trial are unlikely to demonstrate cost-effective-
ness of weight management longer-term for women and
their infants, a future definitive trial would need to con-
sider economic modelling
Women who participated may have been more moti-
vated and interested, but once recruited, follow up and
adherence were good. A further larger trial of effectiveness
of lifestyle information and commercial weight manage-
ment groups is an important next step to consider how
best to support weight management among women with
higher BMIs who have recently given birth.
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